首页> 外文会议>IEEE International Conference on Plasma Science;ICOPS 2012 >Antitumoral effects of combined non thermal plasma and gemcitabine treatments on a MIA PaCa-luc orthotopic pancreatic carcinoma model
【24h】

Antitumoral effects of combined non thermal plasma and gemcitabine treatments on a MIA PaCa-luc orthotopic pancreatic carcinoma model

机译:非热血浆和吉西他滨联合治疗对MIA PaCa-luc原位胰腺癌模型的抗肿瘤作用

获取原文

摘要

Cancer of the exocrine pancreas, especially ductal adenocarcinoma, the most common pancreatic cancer1, is rarely curable and has an overall survival rate of less than 4%. Moreover, chemotherapy and radiotherapy of pancreatic cancer are only, up to now, palliative treatments. New therapeutic approaches are then necessary. Recent results were obtained on the treatment of glioblastoma and colon carcinoma2,3 using non thermal plasma (NTP). They led us to assess the antitumoral effect of NTP alone or in combination with Gemcitabine, a, reference chemotherapeutic agent with radiosensitizing properties, on pancreatic cancer.
机译:外分泌胰腺癌,特别是导管腺癌,是最常见的胰腺癌1,几乎无法治愈,总生存率不到4%。而且,迄今为止,胰腺癌的化学疗法和放射疗法仅仅是姑息疗法。因此需要新的治疗方法。使用非热血浆(NTP)治疗胶质母细胞瘤和结肠癌2,3的最新结果。他们使我们评估了NTP单独或与吉西他滨(一种具有放射增敏特性的参考化疗药物)联合使用对胰腺癌的抗肿瘤作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号